We are live on ! Find out more
TBPH icon

Theravance Biopharma
TBPH

118 hedge funds and large institutions have $775M invested in Theravance Biopharma in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 51 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.35% less ownership

Funds ownership: 83.95% → 82.6% (-1.4%)

6% less funds holding

Funds holding: 125 → 118 (-7)

16% less call options, than puts

Call options by funds: $877K | Put options by funds: $1.04M

29% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 51

30% less capital invested

Capital invested by funds: $1.11B → $775M (-$336M)

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
118
Holders Change
-7
Holders Change %
-5.6%
% of All Funds
2.38%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
36
Reduced
51
Closed
18
Calls
$877K
Puts
$1.04M
Net Calls
-$162K
Net Calls Change
+$825K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$68.6M
2
CAM
Cormorant Asset Management
Massachusetts
+$10.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.59M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$2.62M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$22.4M
2
Ameriprise
Ameriprise
Minnesota
-$19.6M
3
BG
Baupost Group
Massachusetts
-$10.8M
4
RCMNY
Rubric Capital Management (New York)
New York
-$7.41M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$5.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
101
Bank of Montreal
Ontario, Canada
$42K -$32.2K -1,718 -38%
PCM
102
Penserra Capital Management
California
$8K +$10.2K +542 New
SPIA
103
Steward Partners Investment Advisory
New York
$7K – – –
Daiwa Securities Group
104
Daiwa Securities Group
Japan
$5K – – –
WT
105
Whittier Trust
California
$4K – – –
Osaic Holdings
106
Osaic Holdings
Arizona
$3K -$187 -10 -4%
VCM
107
Versant Capital Management
Arizona
$3K – – –
MAM
108
Meeder Asset Management
Ohio
$2K -$9.31K -497 -74%
PA
109
Parallel Advisors
California
$2K – – –
Federated Hermes
110
Federated Hermes
Pennsylvania
$1K -$5.72M -305,116 -100%
GT
111
Glenmede Trust
Pennsylvania
$1K -$4.14K -221 -75%
CHA
112
Carmichael Hill & Associates
Maryland
$1K +$375 +20 +100%
S
113
SignatureFD
Georgia
$1K +$431 +23 +39%
PCFFS
114
Pacific Center for Financial Services
California
$1K +$1.07K +57 New
Millennium Management
115
Millennium Management
New York
$246 +$312K +16,668 New
FCA
116
FinTrust Capital Advisors
South Carolina
$3 +$3.75K +200 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
117
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$3.3M -157,400 Closed
EGM
118
Engineers Gate Manager
New York
– -$1.55M -73,667 Closed
CSS
119
Cubist Systematic Strategies
Connecticut
– -$645K -30,751 Closed
HIM
120
Hillsdale Investment Management
Ontario, Canada
– -$644K -30,700 Closed
SG Americas Securities
121
SG Americas Securities
New York
– -$349K -16,643 Closed
Marshall Wace
122
Marshall Wace
United Kingdom
– -$315K -14,990 Closed
CAC
123
Cowen and Company
New York
– -$287K -13,664 Closed
II
124
Inspire Investing
Idaho
– -$203K -9,672 Closed
PP
125
Paloma Partners
Connecticut
– -$203K -9,636 Closed
2 3 4
5
6

TBPH Hedge Fund Activity: Q3 2020 in Review

118 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Theravance Biopharma (TBPH) for Q3 2020, worth a combined $775M — down 30% from $1.11B a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of TBPH and 12 opened new positions — a net loss of 6 holders — while 51 trimmed existing stakes and 36 added.

The largest buyer was OrbiMed, adding an estimated $68.6M. The largest seller was Jane Street, cutting an estimated $22.4M.

  • 118 institutional investors held Theravance Biopharma (TBPH) as of Q3 2020, down from 125 in Q2 2020.
  • Funds reported $775M of Theravance Biopharma stock for Q3 2020, down 30% quarter-over-quarter.
  • 12 funds opened new Theravance Biopharma positions in Q3 2020 and 18 closed out, a net change of -6 holders.
  • The largest Theravance Biopharma buyer in Q3 2020 was OrbiMed, an estimated $68.6M added.
  • The largest Theravance Biopharma seller in Q3 2020 was Jane Street, an estimated $22.4M sold.

Based on aggregated 13F filings for Q3 2020.